The lawsuit against CVS Health and affiliated entities, alleges improper diversion of savings tied to the federal 340B Drug Pricing Program.

Once prescription costs exceeded $60, roughly two-thirds of patients said they would delay or forgo filling the medication altogether.

The case, brought by Connecticut-based provider group Murphy Medical Associates, stems from COVID-19 testing services delivered during the pandemic at sites across Connecticut and New York.

The leadership transition adds uncertainty for drug approvals, treatment access and regulatory direction.

Nearly three-quarters of small business owners view artificial intelligence as a way to support employees and improve efficiency rather than reduce headcount.

Janus Henderson US (Holdings) Inc. has agreed to a $6.5 million settlement to resolve a proposed class action alleging that its 401(k) retirement plan improperly favored proprietary investment funds, according to filings in the U.S. District Court for the District of Colorado.

The framework links U.S. drug prices to international benchmarks through manufacturer agreements and federal pricing mechanisms, with major implications for high-cost drugs like GLP-1s.

Study finds widespread use of no-cost screenings, with estimated annual savings exceeding $4,000 per family.